Author Archive: Jim Lane

rss feed

Biofuels Digest Index slips to 63.97 as enzyme equities drop

Biofuels Digest Index slips to 63.97 as enzyme equities drop

December 20, 2012 |

The Biofuels Digest Index™ (BDI), a basket of public biofuels stocks, edged downwards 0.22 percent to 63.97 as enzyme equities flagged. For the day, Novozymes (NZMB) fell 1.69 percent to $28.00, while Gevo (GEVO) surged 6.58 percent to $1.62. Among other equities, Verenium (VRNM) shed 6.11 percent to $2.15. Overall, advances and declines were even […]

Read More

Cellulosic Biofuels – the plants, the projects, the progress: new AEC report

Cellulosic Biofuels – the plants, the projects, the progress: new AEC report

December 19, 2012 |

The Advanced Ethanol Council (AEC) released a progress report today on the development of the cellulosic biofuels industry. The release comes on the five year anniversary of the signing of the Renewable Fuel Standard (RFS), and on the heels of Secretary Vilsack’s speech on rural innovation and economic opportunity at the U.S. Chamber of Commerce. The report, for the […]

Read More

Defense bill done: biofuels survive

Defense bill done: biofuels survive

December 18, 2012 |

Unofficial reports indicate that biofuels provisions have survived a House-Senate conference over the Defense bill. According to sources, House and Senate conferees have finished work on their conference report on the National Defense Authorization Act. Sources indicate that  House language prohibiting DOD spending on biofuels has been removed and replaced with a requirement that DOD […]

Read More

Biofuels Venture in crisis? Check samples, suing, extraction technology

Biofuels Venture in crisis? Check samples, suing, extraction technology

December 18, 2012 |

Investors, policy-makers, supply-chain partners, observers – so many stakeholders ask the same question – how do you really know when your favorite biofuels venture is having real trouble as opposed to a non-material slowdown or hiccup. But not every venture is far enough along or transparent enough to offer classic data for analysts or the […]

Read More

Biofuels Venture in crisis? Check ordering, design changes, capacity reductions

Biofuels Venture in crisis? Check ordering, design changes, capacity reductions

December 18, 2012 |

Investors, policy-makers, supply-chain partners, observers – so many stakeholders ask the same question – how do you really know when your favorite biofuels venture is having real trouble as opposed to a non-material slowdown or hiccup. But not every venture is far enough along or transparent enough to offer classic data for analysts or the […]

Read More

Biofuels Venture in crisis? Check staff ratio, milestone payments, downtime

Biofuels Venture in crisis? Check staff ratio, milestone payments, downtime

December 18, 2012 |

Investors, policy-makers, supply-chain partners, observers – so many stakeholders ask the same question – how do you really know when your favorite biofuels venture is having real trouble as opposed to a non-material slowdown or hiccup. In industrial biotechnology as in all business, the laws of gravity apply — and profits are the driver and […]

Read More

Contamination! and other crises: 12 Signs that your favorite biofuels venture may be in trouble

Contamination! and other crises: 12 Signs that your favorite biofuels venture may be in trouble

December 18, 2012 |

Is your favorite biofuels venture in trouble? — or might look in trouble but actually be just fine. Here are 12 tell-tale signs if you’ve “got trouble, right here in River City.” In the game of professional golf, Saturday is traditionally known as “moving day” as the leaders begin to separate themselves from the pack […]

Read More

Verdezyne sells xylose technology to DuPont Industrial Biosciences

Verdezyne sells xylose technology to DuPont Industrial Biosciences

December 18, 2012 |

In California, Verdezyne announced the sale of its proprietary xylose isomerase technology, enabling the metabolism of 5-carbon sugars, to DuPont Industrial Biosciences. Under the terms of the sale, DuPont has purchased rights to Verdezyne’s patented xylose isomerase technology, covered by U.S. Patent Nos. 8,114,974 and 8,093,037, for use in the rapidly-commercializing biofuels and biochemical fields. […]

Read More

Biofuels Digest Index reaches 8-week high as Christmas rally continues

Biofuels Digest Index reaches 8-week high as Christmas rally continues

December 18, 2012 |

The Biofuels Digest Index™ (BDI), a basket of public biofuels stocks, continued its Christmas rally, moving up 1.02 percent to a new eight-week high of 64.11. For the day,Novozymes (NZMB) gained 1.71 percent to $28.48, while KiOR (KIOR) soared 10.49 percent to $6.74. Among other equities, Renewable Energy Group (REGI) dumped 7.72 percent to $5.74. […]

Read More

A Sugar Fix: Proterro, biofuels and affordable, renewable sugars

A Sugar Fix: Proterro, biofuels and affordable, renewable sugars

December 18, 2012 |

Why is making affordable renewable sugars potentially big business? Which intrepid investors have targeted biofuels’ biggest bottleneck? News has been circulating that Proterro raised $3.5 million for a demonstration-scale of their renewable sugars technology, and secured a key patent allowance for their bioreactor system and microorganism. Giving us a good opportunity to review how Proterro, […]

Read More

}